|
| |
| ATGen products
listed by category: |
 |
| Apoptosis, tumour
suppressor and tumour marker [4] |
|
| Cell cycle
proteins [6] |
|
| Growth Factors; Growth Factor Receptors and Hormones [14] |
|
|
Kinases & Phosphatases [6] |
|
|
Lymphocyte Signalling [14] |
|
|
Neurobiology [26] |
|
|
Obesity [2] |
|
|
Receptors and transporters [2] |
|
|
Signalling Intermediates [22] |
|
|
Support Products and Kits [1] |
|
|
Synthesis and Degradation [4] |
|
|
Transcription Factors; DNA Damage and Repair [4] |
|
Apoptosis, tumour suppressor and tumour marker |
 |
|
|
 |
|
|
UBC3002 |
|
Ubiquitin, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
UBC3052 |
|
Ubiquitin, human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
VHL3001 |
|
VHL
protein, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
VHL3051 |
|
VHL
protein, human recombinant |
199,40 |
|
|
|
|
|
|
|
|
|
|
Cell cycle proteins |
|
|
|
|
|
|
|
|
CBP3001 |
|
CEBP-alpha, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
CBP3003 |
|
CEBP-gamma, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
CBP3051 |
|
CEBP-alpha, human recombinant |
199,40 |
|
|
|
|
|
|
|
|
|
CBP3053 |
|
CEBP-gamma, human recombinant |
199,40 |
|
|
|
|
|
|
|
|
|
POZ3001 |
|
GAGA-POZ domain (1-130aa), recombinant |
465 |
|
|
|
|
|
|
|
|
|
POZ3051 |
|
GAGA-POZ domain (1-130aa), recombinant |
199,40 |
|
|
|
|
|
|
|
|
|
|
Growth Factors; Growth Factor Receptors and Hormones |
|
|
|
|
|
|
|
|
ADI3001 |
|
Adiponectin, mouse recombinant |
465 |
|
|
|
|
|
|
|
|
|
ADI3051 |
|
Adiponectin, mouse recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
AGH0401 |
|
Growth
Hormone, monoclonal |
279,40 |
|
|
|
|
|
|
|
|
|
AGH0451 |
|
Growth
Hormone, monoclonal |
193 |
|
|
|
|
|
|
|
|
|
CSF4001 |
|
G-CSF,
human recombinant |
465 |
|
|
|
|
|
|
|
|
|
CSF4051 |
|
G-CSF,
human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
GRH3001 |
|
Growth
Hormone, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
GRH3002 |
|
Growth
Hormone, 20kDa, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
GRH3051 |
|
Growth
Hormone, human recombinant |
737 |
|
|
|
|
|
|
|
|
|
GRH3052 |
|
Growth
Hormone, 20kDa, human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
IFG4001 |
|
Interferon-gamma, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
IFG4051 |
|
Interferon-gamma, human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
PTH3001 |
|
Parathyroid Hormone, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
PTH3051 |
|
Parathyroid Hormone, human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
|
Lymphocyte Signalling |
|
|
|
|
|
|
|
|
AKR0408 |
|
NKp46,
monoclonal |
279,40 |
|
|
|
|
|
|
|
|
|
AKR0458 |
|
NKp46,
monoclonal |
193 |
|
|
|
|
|
|
|
|
|
AKR3006 |
|
KIR2DL3, monoclonal |
279,40 |
|
|
|
|
|
|
|
|
|
AKR3007 |
|
LAIR-1,
monoclonal |
279,40 |
|
|
|
|
|
|
|
|
|
AKR3056 |
|
KIR2DL3, monoclonal |
193 |
|
|
|
|
|
|
|
|
|
AKR3057 |
|
LAIR-1,
monoclonal |
193 |
|
|
|
|
|
|
|
|
|
KIR3001 |
|
KIR2DL1(p58 KIR, CD138), human recombinant |
705 |
|
|
|
|
|
|
|
|
KIR3002 |
|
KIR2DL3
(p58 KIR, CD138), human recombinant |
705 |
|
|
|
|
|
|
|
|
KIR3003 |
|
KIR2DS4
(p50 KIR, CD158), human recombinant |
705 |
|
|
|
|
|
|
KIR3004 |
|
KIR3DL1, human recombinant |
705 |
|
|
|
|
|
|
|
|
KIR3051 |
|
KIR2DL1(p58 KIR, CD138), human recombinant |
279,40 |
|
|
|
|
|
|
|
|
KIR3052 |
|
KIR2DL3
(p58 KIR, CD138), human recombinant |
279,40 |
|
|
|
|
|
|
|
|
KIR3053 |
|
KIR2DS4
(p50 KIR, CD158), human recombinant |
279,40 |
|
|
|
|
|
|
|
|
KIR3054 |
|
KIR3DL1, human recombinant |
279,40 |
|
|
|
|
|
|
|
|
|
Neurobiology |
|
|
|
|
|
|
|
|
SNA2001 |
|
alpha-Synuclein, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2002 |
|
alpha-Synuclein A53T, human recombinant |
185 |
|
|
|
|
|
|
|
|
SNA2003 |
|
alpha-Synuclein A30P, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2004 |
|
alpha-Synuclein A30P/A53T, recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2005 |
|
alpha-Synuclein 112 (NACP112), human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2006 |
|
alpha-Synuclein 61-140, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2007 |
|
alpha-Synuclein 96-140, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2008 |
|
alpha-Synuclein Delta-NAC, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2051 |
|
alpha-Synuclein, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2052 |
|
alpha-Synuclein A53T, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2053 |
|
alpha-Synuclein A30P, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2054 |
|
alpha-Synuclein A30P/A53T, recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2055 |
|
alpha-Synuclein 112 (NACP112), human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2056 |
|
alpha-Synuclein 61-140, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2057 |
|
alpha-Synuclein 96-140, human recombinant |
385 |
|
SNA2058 |
|
alpha-Synuclein Delta-NAC, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA3009 |
|
alpha-Synuclein 1-60, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA3059 |
|
alpha-Synuclein 1-60, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA4001 |
|
alpha-Synuclein E46K, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA4002 |
|
alpha-Synuclein 1-95, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA4051 |
|
alpha-Synuclein E46K, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA4052 |
|
alpha-Synuclein 1-95, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNG2001 |
|
gamma-Synuclein (BCSG1), human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNG2001 |
|
gamma-Synuclein, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNG2051 |
|
gamma-Synuclein (BCSG1), human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNG2051 |
|
gamma-Synuclein, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
|
Obesity |
|
|
|
|
|
|
|
|
LEP3002 |
|
Leptin, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
LEP3052 |
|
Leptin, human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
|
Receptors and transporters |
|
|
|
|
|
|
|
|
RXR3001 |
|
RXR alpha, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
RXR3051 |
|
RXR alpha, human recombinant |
199,40 |
|
|
Signalling Intermediates |
|
|
|
|
|
|
|
|
ACA0401 |
|
alpha crystallin A, monoclonal |
279,40 |
|
|
|
|
|
|
|
|
|
ACA0451 |
|
alpha crystallin A, monoclonal |
193 |
|
|
|
|
|
|
|
|
|
CRA3001 |
|
CRYAA (crystallin alpha A), human recombinant |
465 |
|
|
|
|
|
|
|
|
|
CRA3002 |
|
CRYAB (crystallin alpha B), human recombinant |
465 |
|
|
|
|
|
|
|
|
|
CRA3051 |
|
CRYAA (crystallin alpha A), human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
CRA3052 |
|
CRYAB (crystallin alpha B), human recombinant |
465 |
|
|
|
|
|
|
|
|
|
DNJ3001 |
|
DnaJ (aa 1-376), recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
DNJ3051 |
|
DnaJ (aa 1-376), recombinant |
465 |
|
|
|
|
|
|
|
|
|
DNK2001 |
|
Dnak (aa 385-546), Substrate binding domain,
recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
DNK2051 |
|
Dnak (aa 385-546), Substrate binding domain,
recombinant |
465 |
|
|
|
|
|
|
|
|
|
DNK3001 |
|
Dnak (full length 1-638), recombinant |
465 |
|
|
|
|
|
|
|
|
|
DNK3002 |
|
Dnak (N-term 1-384), ATPase binding domain,
recombinant |
465 |
|
|
|
|
|
|
|
|
|
DNK3003 |
|
Dnak (C-term 385-638), Substrate binding domain,
recombinant |
465 |
|
|
|
|
|
|
|
|
|
DNK3004 |
|
Dnak (aa 508-638), recombinant |
465 |
|
|
|
|
|
|
|
|
|
DNK3051 |
|
Dnak (full length 1-638), recombinant |
132,20 |
|
|
|
|
|
ATGen
|
DNK3052 |
|
Dnak (N-term 1-384), ATPase binding domain,
recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
DNK3053 |
|
Dnak (C-term 385-638), Substrate binding domain,
recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
DNK3054 |
|
Dnak (aa 508-638), recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
PIN3001 |
|
Pin1, human recombinant |
705 |
|
|
|
|
|
|
|
|
|
PIN3051 |
|
Pin1, human recombinant |
279 |
|
|
|
|
|
|
|
|
|
SHP2001 |
|
SHP-1, human recombinant |
705 |
|
|
|
|
|
|
|
|
|
SHP2051 |
|
SHP-1, human recombinant |
279,40 |
|
|
|
|
|
|
Support Products and Kits |
|
|
|
|
|
|
|
|
PMRO401 |
|
ATGen Prestained Protein Markers |
225 |
|
|
Synthesis and Degradation |
|
|
|
|
|
|
|
|
UBC3001 |
|
Ubc9, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
UBC3003 |
|
Ubc7, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
UBC3051 |
|
Ubc9, human recombinant |
199 |
|
|
|
|
|
|
|
|
|
UBC3053 |
|
Ubc7, human recombinant |
199 |
|
|
Transcription Factors; DNA Damage and Repair |
|
|
|
|
|
|
|
|
AHR0401 |
|
SET 7/9, monoclonal |
279 |
|
|
|
|
|
|
|
|
|
AHR0451 |
|
SET 7/9, monoclonal |
123 |
|
|
|
|
|
|
|
|
|
SET3001 |
|
SET7/9 Histone mehyltransferase, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
SET3051 |
|
SET7/9 Histone mehyltransferase, human recombinant |
122,20 |
|
|
Kinases & Phosphatases |
|
|
|
|
|
|
|
|
APP0401 |
|
PP2Ca, monoclonal |
279,40 |
|
|
|
|
|
|
|
|
|
APP0451 |
|
PP2Ca, monoclonal |
193 |
|
|
|
|
|
|
|
|
|
PPC3001 |
|
His-PP2C alpha, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
PPC3051 |
|
His-PP2C alpha, human recombinant |
199,40 |
|
|
|
|
|
|
|
|
|
PTB2001 |
|
PTP-1B, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
PTB2051 |
|
PTP-1B, human recombinant |
199,40 |
|
|
|
|
|
|
|
|
